{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69a1e056a9760df1fba0e483/6a87071ea103c59e02739d63?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Facilitated reintroduction of eliminated eosinophilic esophagitis trigger foods with dupilumab","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69a1e056a9760df1fba0e483/1787234021411-4c12026d-f7d6-4735-afdc-91ba225214ff.jpeg?height=200","description":"<p>In this plain language podcast, the role of dupilumab to facilitate reintroduction of foods that trigger eosinophilic esophagitis (EoE) is discussed, with insights from an allergist, a gastroenterologist, and a patient living with EoE. The podcast aims to provide information to support patient and physician shared decision-making. An overview of EoE and currently available treatment options is provided, and a discussion of their advantages and disadvantages. Finally, results from a recent pilot study in which patients treated with dupilumab were able to reintroduce trigger foods without worsening measures of their EoE are examined.</p><p><br></p>","author_name":"SAGE Publishers"}